Zoltán Giricz

Zoltán Giricz is a Hungarian academic affiliated with Semmelweis University's Doctoral School of Pharmaceutical Sciences, where he serves as an instructor and mentor. His expertise bridges cardiovascular pharmacology and biochemistry, focusing on developing anti-myocardial infarction therapies for metabolic syndrome and studying endogenous cardioprotection mechanisms.

• Primary Affiliation: Semmelweis University
• Previous Positions: Research fellow at San Diego State University (2009-2011), National University of Ireland, Galway (2007-2008), and University of Szeged (2004-2006).

His research emphasizes:

• Pharmacological targeting of cardiotoxicity and protectomiRs
• Extracellular vesicles in cardiac injury and repair
• Translational models of ischemia/reperfusion injury
• Molecular mechanisms of cardioprotection

Analysis of his 15 most recent publications reveals a consistent focus on:

• Cardiac cell signaling pathways (NHE1-NO, AT1 receptors)
• Extracellular vesicle biology in cardiovascular disease
• Drug safety testing and hidden cardiotoxicity
• Translational studies using pig and rodent models
• Molecular networks in cardioprotective microRNAs
• Comparative pathophysiology across species

Scientific honors include:

• Hungarian Academy of Sciences Bolyai Scholarship (2012-2015, 2017-2020)
• ISHR-NA Young Investigator Bursary (2011)
• FEBS Young Scientists Fellowship (2005)
• Leadership roles in OTKA-PD 109051 (2013-2017) and OMAA Thematic Competition (2014)

He contributes to education through:

• PharmD, PhD, and Pharmacist degrees from University of Szeged
• Instructor role in the PhD course 'Pharmacodynamics I' since 2012
• Mentorship of 3 PhD students at Semmelweis University